Evexia Lifecare Board of Directors
Get the latest insights into the leadership at Evexia Lifecare. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Jayesh R Thakkar | Chairman & Managing Director |
| Mr. Hasmukh D Thakkar | Non Exe.Non Ind.Director |
| Ms. Payal Gajjar | Ind. Non-Executive Director |
| Mr. Mohammadraza Makrani | Ind. Non-Executive Director |
| Mr. Kartik B Mistry | Ind. Non-Executive Director |
| Mr. Parth Patel | Ind. Non-Executive Director |
Evexia Lifecare Share price
EVEXIA
2.2
0.01 (-0.45%)Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High
2.27
Today's Low
2.13
52 Week Low
2.07
52 Week High
4.40
The current prices are delayed, login to your account for live prices
LoginEvexia Lifecare FAQs
The board at Evexia Lifecare consists of experienced professionals, including Mr. Jayesh R Thakkar , Mr. Hasmukh D Thakkar , and others, overseeing the company’s strategic and corporate governance.
Directors at Evexia Lifecare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Jayesh R Thakkar is the current chairman at Evexia Lifecare.
Executive directors at Evexia Lifecare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Evexia Lifecare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Evexia Lifecare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.